Krystal Biotech
KRYS
KRYS
245 hedge funds and large institutions have $5.24B invested in Krystal Biotech in 2024 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 100 increasing their positions, 71 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
17% more capital invested
Capital invested by funds: $4.49B → $5.24B (+$750M)
10.68% more ownership
Funds ownership: 89.22% → 99.89% (+11%)
5% more funds holding
Funds holding: 234 → 245 (+11)
Holders
245
Holding in Top 10
7
Calls
$54.5M
Puts
$42.2M
Top Buyers
| 1 | +$393M | |
| 2 | +$143M | |
| 3 | +$80.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$71.3M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$42.9M |
Top Sellers
| 1 | -$89.5M | |
| 2 | -$27.6M | |
| 3 | -$22.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$18.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17.6M |